Throat Lozenges

Global Throat Lozenges Market to Reach US$7.9 Billion by 2030

The global market for Throat Lozenges estimated at US$6.0 Billion in the year 2024, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Hard Candy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Soft segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.5% CAGR

The Throat Lozenges market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Throat Lozenges Market - Key Trends & Drivers Summarized

Throat lozenges, commonly known as cough drops, are medicated tablets or candies designed to soothe throat irritation and suppress coughs. They typically contain active ingredients such as menthol, eucalyptus oil, honey, and various herbal extracts, which provide a cooling and soothing effect on the throat. Some lozenges also include mild anesthetics or antiseptics to reduce pain and fight infection. Available in a variety of flavors, throat lozenges are an over-the-counter remedy widely used to alleviate symptoms associated with colds, flu, and other respiratory conditions. The convenience and ease of use make them a popular choice among consumers seeking quick relief from throat discomfort and cough.

The market for throat lozenges has evolved significantly, driven by advancements in formulation and a growing emphasis on natural and organic ingredients. Manufacturers are increasingly incorporating plant-based extracts and essential oils, responding to consumer demand for more natural health solutions. Innovations have led to lozenges that not only provide symptom relief but also offer additional benefits such as immune support and antioxidant properties. Packaging has also improved, with options like resealable pouches and blister packs enhancing product convenience and shelf life. The availability of sugar-free and diabetic-friendly variants has expanded the market`s reach, catering to health-conscious consumers and those with specific dietary needs. Furthermore, the rise of e-commerce has made throat lozenges more accessible, allowing consumers to purchase a wide range of products online.

The growth in the throat lozenges market is driven by several factors, including the increasing prevalence of respiratory infections and the rising awareness of throat health. Seasonal changes and the global spread of flu and cold viruses have heightened the demand for effective symptomatic relief, boosting lozenge sales. Technological advancements in lozenge manufacturing have resulted in products with enhanced efficacy and faster onset of action. Additionally, the trend towards self-medication and the preference for over-the-counter remedies contribute significantly to market expansion. The growing elderly population, who are more prone to respiratory ailments, is another key driver. Marketing strategies emphasizing natural ingredients and health benefits are resonating well with consumers, further propelling market growth. Lastly, the expansion of distribution channels, particularly in emerging markets, is facilitating wider access to throat lozenges, supporting sustained market growth.

 

SCOPE OF STUDY:

The report analyzes the Throat Lozenges market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Hard Candy, Soft, Compressed); Indication (Sore Throat, Cough & Cold, Throat Diseases)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 87 Featured) -

• Bayer AG
• Cipla Ltd.
• Church & Dwight Co., Inc.
• Blackmores Limited
• Amrutanjan Health Care Ltd.
• Anabolic Laboratories LLC
• Eclipse Pharmacy Solutions Inc.
• Beenz Limited
• Apex Drug House
• Boiron USA
• Blooms The Chemist Management Services Limited
• DC Nutrition Group Inc.
• Bionorica SE
• Beekeeper`s Naturals Inc.
• Clyor Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.